Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD (BREATH-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00648245
Recruitment Status : Completed
First Posted : April 1, 2008
Last Update Posted : February 10, 2011
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
BioMarck Pharmaceuticals, Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2010
  Study Completion Date : July 2010